I agree that this site is using cookies. You can find further informations here.
X
Tanzhu, Guilong
19  results:
OpenAccess-fulltext X
Search for persons X
?
1

DataSheet1_Cost-effectiveness of tumor-treating fields plus..:

Wentao Tian ; Jiaoyang Ning ; Liu Chen...
https://figshare.com/articles/dataset/DataSheet1_Cost-effectiveness_of_tumor-treating_fields_plus_standard_therapy_for_advanced_non-small_cell_lung_cancer_progressed_after_platinum-based_therapy_in_the_United_States_docx/25143188.  , 2024
Link: https://doi.org/10.3389/..
 
?
2

DataSheet1_Cost-effectiveness of tumor-treating fields plus..:

Wentao Tian ; Jiaoyang Ning ; Liu Chen...
doi:10.3389/fphar.2024.1333128.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
3

DataSheet1_Cost-effectiveness of tumor-treating fields plus..:

Wentao Tian ; Jiaoyang Ning ; Liu Chen...
doi:10.3389/fphar.2024.1333128.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
4

Optimal timing and sequence of combining stereotactic radio..:

Wentao Tian ; Xianjing Chu ; Guilong Tanzhu.
https://doi.org/10.1186/s12967-023-04089-4.  , 2023
Link: https://doi.org/10.1186/..
 
?
5

CircRNAs and lung cancer: Insight into their roles in metas..:

Jiaoyang Ning ; Yi Luo ; Liu Chen...
http://www.sciencedirect.com/science/article/pii/S075333222301051X.  , 2023
Link: https://doi.org/10.1016/..
 
?
6

Heterogeneity of tumor immune microenvironment of EGFR/ALK-..:

Xuefeng Xia ; Gang Xiao ; Liu Chen...
https://jitc.bmj.com/content/11/3/e006243.full.  , 2023
Link: https://doi.org/10.1136/..
 
?
7

DataSheet_1_Cost-effectiveness of neoadjuvant pembrolizumab..:

Wentao Tian ; Lishui Niu ; Ziqi Wang...
doi:10.3389/fimmu.2023.1268070.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
8

The protein arginine methyltransferase family (PRMTs) regul..:

Jiaoyang Ning ; Liu Chen ; Gang Xiao...
http://www.sciencedirect.com/science/article/pii/S0753332223012544.  , 2023
Link: https://doi.org/10.1016/..
 
?
9

DataSheet_2_Cost-effectiveness of neoadjuvant pembrolizumab..:

Wentao Tian ; Lishui Niu ; Ziqi Wang...
doi:10.3389/fimmu.2023.1268070.s002.  , 2023
Link: https://doi.org/10.3389/..
 
?
10

Cost-effectiveness of neoadjuvant pembrolizumab plus chemot..:

Wentao Tian ; Lishui Niu ; Ziqi Wang...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268070/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
11

DataSheet_3_Molecular Subtypes and Prognostic Signature of ..:

Guilong Tanzhu ; Na Li ; Zhanzhan Li..
doi:10.3389/fonc.2022.779168.s003.  , 2022
Link: https://doi.org/10.3389/..
 
?
12

Molecular Subtypes and Prognostic Signature of Pyroptosis-R..:

Guilong Tanzhu ; Na Li ; Zhanzhan Li..
https://www.frontiersin.org/articles/10.3389/fonc.2022.779168/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
13

Table_1_Molecular Subtypes and Prognostic Signature of Pyro..:

Guilong Tanzhu ; Na Li ; Zhanzhan Li..
doi:10.3389/fonc.2022.779168.s005.  , 2022
Link: https://doi.org/10.3389/..
 
?
14

The schemes, mechanisms and molecular pathway changes of Tu..:

Guilong Tanzhu ; Liu Chen ; Gang Xiao...
https://doi.org/10.1038/s41420-022-01206-y.  , 2022
Link: https://doi.org/10.1038/..
 
?
15

Image_1_Molecular Subtypes and Prognostic Signature of Pyro..:

Guilong Tanzhu ; Na Li ; Zhanzhan Li..
doi:10.3389/fonc.2022.779168.s004.  , 2022
Link: https://doi.org/10.3389/..
 
1-15